ArticleBMC neurology2026
Geographical disparities and spatial non-stationarity in stroke prevalence across China: a Bayesian analysis.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAs stroke remains a major public health challenge in China, numerous studies have characterized the epidemiological features and distribution of stroke prevalence across provinces. However, conventional non-spatial analytical approaches may lack the capability to capture spatial dependency and regional variation in the impact of risk factors. This study aims to estimate province-level stroke prevalence in China and quantify how its association with individual-level risk factors varies across provinces, accounting for spatial dependency.
methodsIn this study, 19,713 adults were included from the fourth China Health and Retirement Longitudinal Study (CHARLS 2018), spanning 28 provinces, autonomous regions, and municipalities. Within each province, prevalence estimates were standardized to the 7th National Census (2020) distribution of age, sex, and residence type. Stroke prevalence and 95% Bayesian credible intervals (BCIs) were estimated by a Bayesian spatially varying coefficient model. Global and local Moran's I statistics were used to assess spatial autocorrelation and identify clustering patterns. Eight metabolic, lifestyle, and socioeconomic risk factors were considered: lower educational attainment, hypertension, diabetes, heart disease, dyslipidemia, smoking, alcohol consumption, and physical inactivity. The model estimated how the association of each with stroke varied across provinces.
resultsStroke prevalence at province level in China showed marked geographic disparities, ranging from 1.89% (95% BCI: 0.92%-3.61%) to 8.64% (95% BCI: 6.98%-10.63%). A distinct "North-high, South-low" spatial gradient was observed, with significant positive spatial autocorrelation (I = 0.428, p < 0.001). Local cluster analysis identified high-high clusters in Northeast and North China and low-low clusters in South and East China. Except for low educational attainment, the association between stroke prevalence and smoking, drinking, physical inactivity, hypertension, diabetes, dyslipidemia, and heart disease exhibited significant provincial variation. Hypertension showed the strongest association with stroke, with odds ratios ranging from 2.39 to 3.38 across provinces.
conclusionsStroke burden in China is spatially clustered, and the associations between stroke and its risk factors vary markedly across provinces rather than being uniform nationwide. By integrating spatial non-stationarity with census-based demographic standardization, this study provides spatially refined evidence to support region-specific stroke-prevention strategies and optimize the allocation of healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.